Plataforma ISCIII of Biobanks & Biomodels The Vall d'Hebron University Hospital Biobank (HUVH Biobank) was authorised in 2013. From 2010 to 2013 it was part of the "National Biobank Network", promoted by the Carlos III Health Institute. This network subsequently transformed into the Biobank Platform and finally the "Carlos III Health Institute Platform for Biobanks and Biomodels" (PISCIIIBB). The platform is currently organised into four hubs that include, at the national level, the participation of 55 biobanks, 20 centres that develop organoids, 18 that develop animal disease models and 19 centres with 3D printing activities. The Platform's website offers a one-stop service that makes it possible to locate human samples, biomodels and/or specialised services among all the centres that are part of the platform. More information Europeen Network of Biobanks The "European Biobank Network", BBMRI-ERIC, is a platform that fosters contact between researchers and biobanks within the European Community. The aim is to boost biomedical research by improving interoperability between biobanks and research centres. It consists of 22 countries, including Spain —which has participate as an observer member since 2022— along with Switzerland, Turkey, Cyprus and Lithuania. Its infrastructure is based on the networking of existing biobanks to allow researchers effective access to biological samples and data relevant to biomedical research in compliance with the legal framework established in each of the participating member states. If you want to find biological samples within Europe, the best way is through its website. More information CERCAGINYS The purpose of this platform is to facilitate the access by the public, private business and industrial sectors to centres with highly qualified personnel from different fields (cultural, agri-food, energy, logistics, education, industry, technology, etc.). The aim is to promote knowledge transfer to the business sector and society, by providing support, advice and impetus for the creation of start-ups in Catalonia. More information Catalan Tumour Bank Network In 2002, the Catalan Cancer Plan was the driving force behind the creation of the Catalan Tumour Bank Network (XBTC). The HUVH Biobank Tumour Bank is part of this Network. The tissue samples of malignant neoplasms and healthy tissue samples belong to each of the 11 associated biobanks throughout Catalonia. Research groups can request samples through the hub of their institution belonging to the network, or through the coordinating hub that will distribute them to the rest of the banks. More information in the 'professionls' section of its website Spanish Clinical Research Network VHIR's ARO (Academic Research Organisation) is part of the ISCIII-funded Platform for Clinical Research Support, SCReN (Spanish Clinical Research Network), a collaborative network structure supporting independent and academic clinical research. It consists of 34 research units (CRUs) distributed throughout Spain. The aim is to provide scientific-technical support and to meet the needs of independent clinical research. ARO has periodically renewed its participation in SCReN since 2014, receiving funding from ISCIII through the Platforms programmes. More information European Clinical Research Infrastructure Network Through SCReN, VHIR's ARO (Academic Research Organisation) is part of ECRIN (European Clinical Research Infrastructure Network), an initiative created for advancement and international cooperation in clinical trials in Europe. It allows researchers to conduct multinational clinical trials using the network's services, infrastructures and tools. It consists of 12 members across Europe who are committed to generating scientific evidence to optimise medical practices. More information European Infrastructure for Translational Medicine A European initiative designed to support translational medical research so that research and discoveries translate into benefits for patients. It provides access to knowledge and facilities from over 144 leading academic centres across Europe. It is focused on improving and optimising the development of drugs, vaccines and diagnostic tests to overcome barriers to innovation in health. The national hub is coordinated by the Carlos III Health Institute, with the participation of 15 accredited health research institutes that add value to health research and constitute the perfect channel for the translation of biomedical knowledge into clinical practice, and finally on to the patient. More information Clinical Research Management Entity Network REGIC is the first association of clinical research management organisations created in Spain at the request of professionals. Its purpose is to share experiences and create a space for interaction and training in the management of R&D&I in healthcare. It is made up of 50 associate members, of which 27 are Health Research Institutes (IIS) accredited by the ISCIII. The REGIC members are distributed among the 15 Autonomous Regions. More information
